ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000451 | dendritic cell | 60 | |
| CL_0000784 | plasmacytoid dendritic cell | 55 | |
| CL_0000990 | conventional dendritic cell | 45 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| CFP | 19 | 41% ± 20% | 0 | 10 | |
| CLEC10A | 16 | 42% ± 19% | 1 | 8 | |
| CSF2RA | 24 | 50% ± 21% | 2 | 15 | |
| CD86 | 23 | 38% ± 14% | 2 | 13 | |
| MS4A6A | 22 | 49% ± 18% | 2 | 18 | |
| IFI30 | 19 | 46% ± 25% | 2 | 17 | |
| JAML | 20 | 46% ± 17% | 2 | 27 | |
| LY86 | 18 | 40% ± 21% | 2 | 18 | |
| RNASE6 | 17 | 41% ± 19% | 2 | 18 | |
| RGS1 | 26 | 55% ± 25% | 3 | 46 | |
| MNDA | 20 | 44% ± 17% | 3 | 14 | |
| HCK | 19 | 36% ± 15% | 3 | 17 | |
| CXCL16 | 19 | 44% ± 17% | 3 | 23 | |
| SPI1 | 28 | 56% ± 25% | 4 | 30 | |
| TYROBP | 29 | 72% ± 24% | 4 | 40 | |
| LST1 | 26 | 58% ± 22% | 4 | 25 | |
| PTPRC | 30 | 57% ± 23% | 4 | 67 | |
| GPR183 | 27 | 56% ± 18% | 4 | 42 | |
| PLEK | 27 | 48% ± 23% | 4 | 44 | |
| CD83 | 25 | 60% ± 25% | 4 | 29 | |
| CPVL | 23 | 55% ± 18% | 4 | 18 | |
| HLA-DQA2 | 21 | 44% ± 18% | 4 | 18 | |
| FGL2 | 21 | 54% ± 19% | 4 | 21 | |
| FCER1G | 22 | 69% ± 25% | 4 | 32 | |
| CYTIP | 23 | 42% ± 20% | 4 | 57 | |
| HCLS1 | 23 | 53% ± 22% | 4 | 63 | |
| C1orf162 | 20 | 60% ± 24% | 4 | 37 | |
| TNFAIP2 | 19 | 32% ± 16% | 4 | 27 | |
| ITGB2 | 22 | 63% ± 25% | 4 | 59 | |
| LGALS2 | 18 | 47% ± 17% | 4 | 19 |
| GO_0071801 | Biological process | regulation of podosome assembly |
| GO_1902445 | Biological process | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death |
| GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
| GO_0051445 | Biological process | regulation of meiotic cell cycle |
| GO_0022417 | Biological process | protein maturation by protein folding |
| GO_0016045 | Biological process | detection of bacterium |
| GO_1902622 | Biological process | regulation of neutrophil migration |
| GO_0097053 | Biological process | L-kynurenine catabolic process |
| GO_0043308 | Biological process | eosinophil degranulation |
| GO_0010956 | Biological process | negative regulation of calcidiol 1-monooxygenase activity |
| GO_0032966 | Biological process | negative regulation of collagen biosynthetic process |
| GO_0070667 | Biological process | negative regulation of mast cell proliferation |
| GO_0060333 | Biological process | type II interferon-mediated signaling pathway |
| GO_1903979 | Biological process | negative regulation of microglial cell activation |
| GO_0002606 | Biological process | positive regulation of dendritic cell antigen processing and presentation |
| GO_0031346 | Biological process | positive regulation of cell projection organization |
| GO_0002408 | Biological process | myeloid dendritic cell chemotaxis |
| GO_0006569 | Biological process | tryptophan catabolic process |
| GO_0033590 | Biological process | response to cobalamin |
| GO_0042270 | Biological process | protection from natural killer cell mediated cytotoxicity |
| GO_0010466 | Biological process | negative regulation of peptidase activity |
| GO_2001269 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO_0034695 | Biological process | response to prostaglandin E |
| GO_0071731 | Biological process | response to nitric oxide |
| GO_0002091 | Biological process | negative regulation of receptor internalization |
| GO_0051461 | Biological process | positive regulation of corticotropin secretion |
| GO_2000669 | Biological process | negative regulation of dendritic cell apoptotic process |
| GO_0010957 | Biological process | negative regulation of vitamin D biosynthetic process |
| GO_1990051 | Biological process | activation of protein kinase C activity |
| GO_0070665 | Biological process | positive regulation of leukocyte proliferation |
| Cell type name | dendritic cell |
| Synonyms | |
| Description | A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative). |
| Parent | CL_0000113 |